See more : Premier American Uranium Inc. (PUR.V) Income Statement Analysis – Financial Results
Complete financial analysis of Nyrada Inc. (NYR.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Nyrada Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- Sichuan Etrol Technologies Co., Ltd. (300370.SZ) Income Statement Analysis – Financial Results
- Sinher Technology Inc. (4999.TW) Income Statement Analysis – Financial Results
- HAMPTON SKY REALTY LIMITED (HAMPTON.BO) Income Statement Analysis – Financial Results
- Aecc Aero-Engine Control Co.,Ltd. (000738.SZ) Income Statement Analysis – Financial Results
- S4 Capital plc (SFOR.L) Income Statement Analysis – Financial Results
Nyrada Inc. (NYR.AX)
About Nyrada Inc.
Nyrada Inc., a pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular, neurodegenerative, and chronic inflammatory diseases. Its products in the drug development stage include PCSK9 inhibitor for the treatment of high blood LDL-cholesterol levels in patients poorly responsive to or unable to take statin drugs; a neuroprotectant drug to reduce the disability in patients with ischaemic stroke and traumatic brain injury; a drug to treat pain associated with peripheral nerve damage; and a drug to treat autoimmune diseases, such as psoriasis. The company has collaboration with Walter Reed Army Institute of Research and University of New South Wales, Sydney. Nyrada Inc. was incorporated in 2017 and is based in Gordon, Australia.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 1.43M | 1.09M | 2.34M | 1.13M | 486.34K | 0.00 |
| Cost of Revenue | 5.16K | 6.56K | 4.75K | 1.80K | 1.48K | 1.41K | 119.00 |
| Gross Profit | -5.16K | 1.42M | 1.09M | 2.33M | 1.12M | 484.93K | -119.00 |
| Gross Profit Ratio | 0.00% | 99.54% | 99.57% | 99.92% | 99.87% | 99.71% | 0.00% |
| Research & Development | 2.02M | 6.44M | 1.84M | 2.17M | 1.40M | 1.04M | 689.52K |
| General & Administrative | 0.00 | 1.05M | 1.04M | 1.41M | 1.58M | 901.23K | 489.23K |
| Selling & Marketing | 0.00 | 1.65M | 1.98M | 2.03M | 3.56M | 1.96M | 975.30K |
| SG&A | 2.53M | 2.70M | 3.02M | 3.43M | 5.14M | 2.86M | 1.46M |
| Other Expenses | 0.00 | 1.43M | 1.09M | 2.34M | 1.13M | 0.00 | 0.00 |
| Operating Expenses | 4.56M | 9.14M | 4.86M | 5.60M | 6.54M | 3.90M | 2.15M |
| Cost & Expenses | 4.56M | 9.15M | 4.86M | 5.60M | 6.54M | 3.90M | 2.15M |
| Interest Income | 160.43K | 149.48K | 13.88K | 3.97K | 140.36K | 19.36K | 4.09K |
| Interest Expense | 0.00 | 0.00 | 1.39K | 5.61K | 140.36K | 650.85K | 238.30K |
| Depreciation & Amortization | 5.16K | 6.56K | 4.75K | 1.80K | 1.48K | 1.41K | 119.00 |
| EBITDA | -4.60M | -9.25M | -4.86M | -3.52M | -5.63M | -3.44M | -2.18M |
| EBITDA Ratio | 0.00% | -639.46% | -444.10% | -239.79% | -580.93% | -802.11% | 0.00% |
| Operating Income | -4.56M | -9.15M | -4.86M | -5.60M | -6.54M | -3.90M | -2.15M |
| Operating Income Ratio | 0.00% | -639.92% | -444.53% | -239.87% | -581.06% | -802.40% | 0.00% |
| Total Other Income/Expenses | -41.04K | -102.26K | -1.05M | 11.46K | -140.36K | -631.21K | -262.12K |
| Income Before Tax | -4.60M | -9.25M | -5.03M | -3.53M | -5.77M | -4.09M | -2.42M |
| Income Before Tax Ratio | 0.00% | -647.08% | -459.46% | -150.95% | -513.03% | -841.97% | 0.00% |
| Income Tax Expense | -3.22M | -1.44M | -1.05M | -5.31 | -4.00 | 4.11 | 1.00 |
| Net Income | -1.39M | -7.82M | -3.97M | -3.53M | -5.77M | -4.09M | -2.42M |
| Net Income Ratio | 0.00% | -546.63% | -363.28% | -150.95% | -513.03% | -841.97% | 0.00% |
| EPS | -0.01 | -0.05 | -0.03 | -0.03 | -0.05 | -0.04 | -0.02 |
| EPS Diluted | -0.01 | -0.05 | -0.03 | -0.03 | -0.05 | -0.04 | -0.02 |
| Weighted Avg Shares Out | 163.01M | 156.01M | 156.01M | 116.74M | 109.38M | 109.38M | 109.38M |
| Weighted Avg Shares Out (Dil) | 163.01M | 156.01M | 156.01M | 116.74M | 109.38M | 109.38M | 109.38M |
Source: https://incomestatements.info
Category: Stock Reports